Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 1.17% 260.00 258.00 262.00 260.00 257.00 257.00 77,126 16:14:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 14.8 176

Eco Animal Health Share Discussion Threads

Showing 401 to 424 of 1125 messages
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
15/7/2013
07:50
Topvest, as I understand it the change from 10-20 years is just a change in accounting practice but one with a positive impact nevertheless. However, the interesting question this poses (and one I've raised before on this board but I don't recall an answer) is how long EAH have left on thier patent for Aivlosin. This is the major factor influencing the value they can extract from this molecule because once it becomes generic, then their margin will drop significantly. Interesting that there is no mention of the anti-viral research. I'd like to know where things are at with this even though its very speculative.
audigger
13/7/2013
11:54
My understanding is that third party distributors take about a 50% margin. A bigger company, operating internationally and with it's own sales forces could improve EAH's profits nearly three fold. Full value for the company is probably around 600p so patience is called for.
aimingupward2
13/7/2013
11:30
The true value of Aivlosin is far greater than the present market cap which will be realised on further US registrations and subsequent sales. I am expecting corporate news in the next 6 months.
ltinvestor
13/7/2013
10:13
topvest Doubt it will be acquired it's already expensive so with the usual markup at least 30% and the current earnings i think it would be considerably overpriced but you never know there's always someone! Woody
woodcutter
13/7/2013
07:06
Yes, results are still quite skewed by drug registration and set-up costs. This is a very high quality business though and has the potential for long term growth over a long time period. The results for last year were positively impact by a change in the life of drug registration intangibles from 10 to 20 years which improved profits by £1.3m. It has been a bit of a "jam tomorrow" stock, but things are progressing in the right direction. There is still significant upside if the Group is acquired by a major with their own distribution network.
topvest
12/7/2013
11:20
Woody : > Good points - You ahve confirmed my doubts - Well done with ANP - Had dropped off my radar screen wwhen was Kirotech. Looks imprssive .
pugugly
12/7/2013
09:03
Can't argue that the results are impressive and all the financials seem strong , P&L BS and CFlow, but the valuation looks a bit steep, compared to others in the sector, particularly ANP one of my core holdings. Can't see that there's much margin for error so on a risk reward i'm a little concerned to enter now. Looked at it several times a few years ago when it was below 140p, looked expensive then too so wtfdik! Price earnings ratios figs from DLook: (hard to be sure if these are fair comparisons but the ANP disparity does look wide) ANP 12.4 DPH 21.6 EAH 51.7 GNS 26.2 I think ANP are playing a bit of catch up too. Anyone seen any forecasts for this forth coming year. Woody
woodcutter
12/7/2013
07:25
Agreed results look promising but pe still very high. Post tax eps of 4.9 leaves on a trailing p/e ratio of some 49 - very much jam tomorrow.[ I think this p/e is correct but could someone double check) The house broker Cenkos should be hanging their head in shame as they were forcasting eps of 10.4p and a dividend of 4.3p Missed on both. For debate how far off 2014 results will they be ? Their previous forecast (Refs May) was for pretax of £9 million and eps of 13.2p - (imo) now unlikely to be met uless very significant increase in revenue and margins. Thoughts ??
pugugly
12/7/2013
06:59
Topvest, Question which you allude to, is how does EAH get to the next level? I cannot help feel that it will NOT be just an organic story here, the momentum in the business is very good currently and will NOT go unnoticed. This area is becoming more and more important as it enters our foodchain! smell
smelleroo
12/7/2013
06:54
Yes, very pleased with results especially increasing margins and the prospect of further US registrations.Slow burner that will eventually be taken out at a very nice premium imo.
ltinvestor
12/7/2013
06:53
All looks very promising. I suspect this may now attract some higher profile write-ups and broaden interest which should be good for the share price Wouldn't like to predict the share price move today. In theory it should have no problem heading back to 280 in the short-term, but this is an AIM share and anything is possible!
audigger
12/7/2013
06:36
Results out today - they look pretty good and the outlook is very promising with improving margins and significant turnover growth. Still investing lots in product development, but still able to self finance this. 4p dividend is an acceptable return until we wait for this business to really reach it's peak - how long will that take I wonder?
topvest
01/7/2013
08:06
Results due this month should show an improving upward trend and hopefully a good increase in dividend.
ltinvestor
02/5/2013
20:12
Patience still needed. I think we are 2/3 years off the exit!
topvest
02/5/2013
09:52
This really should be EAH year given the amount of time and investment that the company has put into its development. I was therefore surprised to see these sell off back to pre- FDA approval levels. Looking forward to the next set of results which should see the full financial benefits for Aivlosin in the USA.
shroder
01/5/2013
11:46
It's the small parcels of buys which will get this share price back up to where it belongs (260p at least). keep buying small amounts folks.
sirgainalot
01/5/2013
10:01
Hope so. Am going to add another lot this week.
audigger
01/5/2013
08:34
Yes, I note that the maximum you could get hold of earlier was 2,500 as against 10,000 last week and that the price is edging up. Looks to me like the overhang has been cleared and that a steady movement back up to the 260-270 range is quite on the cards.
pentangle
01/5/2013
08:15
Still only small quantities available.
shroder
25/4/2013
12:27
Excellent opportunity to get a reasonable holding. A few weeks back you could only get these 500 at a time, but of late they have been available in 10,000 lots and even today you could get 5,000 at a go. I have hoovered up a few :-)
pentangle
25/4/2013
12:00
I got the exact same response! Impressed to his openess and reassured by the apparent reason for the drop.....
audigger
25/4/2013
11:49
In reply to my query Mr Lawrence of EAH has promptly replied as follows "Our brokers, Cenkos, tell me that Killicks have been selling just a few of their 1m shares for some clients and as you can see from the link to the London Stock Exchange on our website, the volumes are simply a number of very small retail sales. The market makers are still paranoid about holding any marginally liquid AiM stocks and will mark prices down rapidly. As ever, our institutional holders, who hold about 80% of the company, do not buy small amounts of stocks and when our brokers have enough shares to offer them, they will....which may be today? They are trying! Meanwhile, as we are in a closed period, the company may not buy into treasury and the directors may not deal at these attractive levels which is somewhat frustrating timing! There is nothing more to add at this time. Thank you for your support and for being in touch."
cnx
25/4/2013
07:36
looks like any selling pressure in EAH has eased and probably gone...guess we are going back up. Hopefully anyway! smell
smelleroo
25/4/2013
07:17
Have topped-up. If I can free up some more cash I will top-up again.
audigger
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200129 17:36:22